ENGN Company Profile and Key Details

enGene Holdings Inc. (NASDAQ:ENGN) closed at $1.79 USD, gaining $0.03 (1.70%) from the previous close of $1.76. The stock is currently mid-range between its 52-week high and low $1.40 and $12.25. With a market capitalization of about $91.64 million, enGene Holdings Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.28). Key stats such as the average daily volume over the past year has been around 1.91 million shares, volume is running light vs its 52-week average. Headquartered in Montreal, QC, enGene Holdings Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Ronald H. W. Cooper, the company employs approximately 82 people and listed since February 01, 2022. Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm.

ENGN has shown mixed momentum, gaining 9.64% over the past week and -2.67% over the past quarter, though year-to-date performance is up 0.78%. Short-term trend indicators are bearishly aligned (SMA20 1.73%, SMA50 6.13%, SMA200 55.16%). The stock’s 14-day RSI is 52.54 (neutral), while the ATR of 0.71 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -18.12% below its high and over 278.49% above its low. Average 10-day trading volume of 713.35 thousand shares is below the 3-month average of 1.94 million, indicating normal recent market interest.

enGene Holdings Inc. has 66.99 million shares outstanding. The public float is 19.13 million shares, elevated short interest at 3.02% of float. This equals 1.64 million shares. The short ratio is 1.32 days. Institutional investors hold 107.0% of the float. Insiders own 0.09%.

enGene Holdings Inc. last paid a dividend of 0.7 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.36. This means the shares are trading above this model’s fair value.

enGene Holdings Inc. generated EPS of -$2.29 over the past year. Five-year average earnings growth is -255.92%. Wall Street analysts project EPS growth of 9.16% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 5 Strong Buy ratings, 6 Buy ratings, 4 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $33.00 to $2.00. The high target offers 1743.58% upside. The low target suggests 11.73% downside. The mean target is $16.57. This offers 825.7% upside. enGene Holdings Inc. earnings surprise history is a mixed track record. The quarter that ended June 15, 2026, missed forecasts by -10.42%. The prior quarter beat by -10.42%. Over the last six quarters, Apple has recorded several small beats. These include 14.46% in September 10, 2025.

Our AI price prediction model suggests that enGene Holdings Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.15%, with price expected at $1.68 by August 14, 2026, within a range of $1.63 to $1.74 3-Month Outlook: Projected fall of -50.28%, reaching $0.89 by October 29, 2026, with a range of $0.56 to $1.21. 1-Year Outlook: Projected loss of -95.53%, with price at $0.08 by July 30, 2027, within a range of $0.00 to $0.00.

enGene Holdings Inc. (NASDAQ:ENGN) shares are flat 0.78% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows enGene Holdings Inc. trading at a premium to the broader market with a P/E of -1.33. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $19.33, suggesting 979.89% upside. Our AI forecast model points to short-term weakness (-6.15% over two weeks), a medium-term fall (-50.28% over three months), and a longer-term loss (-95.53% over one year), with expected trading ranges indicating moderate volatility.

enGene Holdings Inc. trades at a P/E ratio of -1.33, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.48 suggesting the stock is closer to book value. The P/FCF stands at -0.81, also below market averages.